BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36272051)

  • 1. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells.
    Rockwood SJ; Arzt M; Sharma A
    Curr Cardiol Rep; 2022 Dec; 24(12):2121-2129. PubMed ID: 36272051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes.
    Liu J; Wu S; Zhang Y; Wang C; Liu S; Wan J; Yang L
    Stem Cell Res Ther; 2023 Sep; 14(1):249. PubMed ID: 37705046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function.
    Marchiano S; Hsiang TY; Khanna A; Higashi T; Whitmore LS; Bargehr J; Davaapil H; Chang J; Smith E; Ong LP; Colzani M; Reinecke H; Yang X; Pabon L; Sinha S; Najafian B; Sniadecki NJ; Bertero A; Gale M; Murry CE
    Stem Cell Reports; 2021 Mar; 16(3):478-492. PubMed ID: 33657418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails.
    Yiangou L; Davis RP; Mummery CL
    Stem Cell Reports; 2021 Mar; 16(3):385-397. PubMed ID: 33306986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes.
    Liu J; Zhang Y; Han L; Guo S; Wu S; Doud EH; Wang C; Chen H; Rubart-von der Lohe M; Wan J; Yang L
    Stem Cell Reports; 2022 Mar; 17(3):522-537. PubMed ID: 35180394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
    Choi SW; Shin JS; Park SJ; Jung E; Park YG; Lee J; Kim SJ; Park HJ; Lee JH; Park SM; Moon SH; Ban K; Go YY
    Antiviral Res; 2020 Dec; 184():104955. PubMed ID: 33091434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
    Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
    Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection.
    Wang R; Hume AJ; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Le Suer J; Huang J; Olejnik J; Villacorta-Martin C; Bullitt E; Hinds A; Ghaedi M; Rollins S; Werder RB; Abo KM; Wilson AA; Mühlberger E; Kotton DN; Hawkins FJ
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L462-L478. PubMed ID: 35020534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes.
    Linn AK; Manopwisedjaroen S; Kanjanasirirat P; Borwornpinyo S; Hongeng S; Phanthong P; Thitithanyanont A
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Effects of Cardiomyocyte Injury in COVID-19.
    Siddiq MM; Chan AT; Miorin L; Yadaw AS; Beaumont KG; Kehrer T; Cupic A; White KM; Tolentino RE; Hu B; Stern AD; Tavassoly I; Hansen J; Sebra R; Martinez P; Prabha S; Dubois N; Schaniel C; Iyengar-Kapuganti R; Kukar N; Giustino G; Sud K; Nirenberg S; Kovatch P; Albrecht RA; Goldfarb J; Croft L; McLaughlin MA; Argulian E; Lerakis S; Narula J; García-Sastre A; Iyengar R
    J Virol; 2022 Jan; 96(2):e0106321. PubMed ID: 34669512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.
    Sharma A; Garcia G; Wang Y; Plummer JT; Morizono K; Arumugaswami V; Svendsen CN
    Cell Rep Med; 2020 Jul; 1(4):100052. PubMed ID: 32835305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection.
    Dmytrenko O; Lavine KJ
    Viruses; 2022 May; 14(6):. PubMed ID: 35746609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts.
    Li X; Hu H; Liu W; Zhang Q; Wang Y; Chen X; Zhu Y; Hu Z; Wang M; Ma J; Leng L
    Stem Cell Res Ther; 2023 Dec; 14(1):361. PubMed ID: 38087340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.
    Ardestani A; Maedler K
    Front Endocrinol (Lausanne); 2020; 11():585922. PubMed ID: 33162939
    [No Abstract]   [Full Text] [Related]  

  • 15. Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development.
    Kim JH; Kim J; Kim WJ; Choi YH; Yang SR; Hong SH
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33202948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19.
    Satta S; Rockwood SJ; Wang K; Wang S; Mozneb M; Arzt M; Hsiai TK; Sharma A
    Circ Res; 2023 May; 132(10):1405-1424. PubMed ID: 37167356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model.
    Lian Q; Zhang K; Zhang Z; Duan F; Guo L; Luo W; Mok BW; Thakur A; Ke X; Motallebnejad P; Nicolaescu V; Chen J; Ma CY; Zhou X; Han S; Han T; Zhang W; Tan AY; Zhang T; Wang X; Xu D; Xiang J; Xu A; Liao C; Huang FP; Chen YW; Na J; Randall G; Tse HF; Chen Z; Chen Y; Chen HJ
    Nat Commun; 2022 Apr; 13(1):2028. PubMed ID: 35440562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril.
    Huang X; Fan W; Sun J; Yang J; Zhang Y; Wang Q; Li P; Zhang Y; Zhang S; Li H; Wang J; Feng L; Zhao J; Chen L; Qu L
    Antiviral Res; 2023 Jul; 215():105636. PubMed ID: 37207821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
    Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
    Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.
    Kwon Y; Nukala SB; Srivastava S; Miyamoto H; Ismail NI; Jousma J; Rehman J; Ong SB; Lee WH; Ong SG
    Stem Cell Res Ther; 2020 Nov; 11(1):514. PubMed ID: 33256833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.